Quote:
Originally Posted by Zeta13Girl
Hey Katy, I haven't heard much about rBGH but I will definitly talk to my dad about it as he works for a pharmaceutical company and usually has first hand knowledge of things in this area....As he informed me not to get the Gardisil shot because of several incidents of blood clots and death resulting from receiving the shot.
Anybody else thats interested I will post whatever info my dad tells me he's read on it from the medical journals and stuff.
|
CRASH! Before anyone decides not to get the Gardisil shot due to this post, here is the prescribing information from the Gardisil site. To get a drug approved, you have to evaluate all reported side effects and determine if they are truly due to the drug or were basically occurring in the patient incidentally. The true side effects of gardisil are minor reactions. The following are the reported side effects which were NOT statistically significant (i.e no higher risk when compared to a placebo shot)
Out of the entire study population (25,274 subjects), only 0.05% of the reported serious systemic
adverse reactions were judged to be vaccine related by the study investigator. The most frequently
reported serious systemic adverse reactions for GARDASIL compared to AAHS control or saline placebo
and regardless of causality were:
Headache [0.02% GARDASIL (3 cases) vs. 0.02% AAHS Control (2 cases)],
Gastroenteritis [0.02% GARDASIL (3 cases) vs. 0.02% AAHS Control (2 cases)],
Appendicitis [0.03% GARDASIL (4 cases) vs. 0.01% AAHS Control (1 case)],
Pelvic inflammatory disease [0.02% GARDASIL (3 cases) vs. 0.04% AAHS Control (4 cases)],
Urinary tract infection [0.02% GARDASIL (2 cases) vs. 0.02% AAHS Control (2 cases)],
Pneumonia [0.02% GARDASIL (2 cases) vs. 0.02% AAHS Control (2 cases)],
Pyelonephritis [0.02% GARDASIL (2 cases) vs. 0.03% AAHS Control (3 cases)],
Pulmonary embolism [0.02% GARDASIL (2 cases) vs. 0.02% AAHS Control (2 cases)].
One case (0.007% GARDASIL: 0.0% AAHS Control or Saline Placebo) of bronchospasm; and 2
cases (0.02% GARDASIL: 0.0% AAHS Control or Saline Placebo) of asthma were reported as serious
systemic adverse reactions that occurred following any vaccination visit.
In addition, there was 1 subject in the clinical trials, in the group that received GARDASIL, who
reported two injection-site serious adverse reactions (injection-site pain and injection-site joint movement
impairment).
Deaths in the Entire Study Population
Across the clinical studies,
24 deaths were reported in 25,274 (GARDASIL N = 13,686; AAHS Control
N = 11,004, saline placebo N = 584) subjects (9- through 45-year-old girls and women; and 9- through
15-year-old boys).
The events reported were consistent with events expected in healthy adolescent and
adult populations. The most common cause of death was motor vehicle accident (4 subjects who
received GARDASIL and 3 AAHS Control subjects), followed by overdose/suicide (2 subjects who
received GARDASIL and 2 subjects who received AAHS Control),
and pulmonary embolus/deep vein
thrombosis (1 subject who received GARDASIL and 1 AAHS Control subject). In addition, there were 2
cases of sepsis, 1 case of pancreatic cancer, 1 case of arrhythmia, 1 case of pulmonary tuberculosis, 1
case of hyperthyroidism, 1 case of post-operative pulmonary embolism and acute renal failure, and 1
case of systemic lupus erythematosus in the group that received GARDASIL; 1 case of asphyxia, and 1
case of acute lymphocytic leukemia in the AAHS Control; and 1 case of medulloblastoma in the saline
placebo group.
According to this data, clots and death were not related to the gardisil shot. Remember that association does NOT equal causation!
End Crash!